Morningstar

PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning

DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ -- PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects ...
Medscape

Will This Urine Test Be a Biopsy Killer for PC?

An experimental urine test can detect aggressive prostate cancers in men on active surveillance, potentially sparing them from repeated biopsies, researchers reported on Friday. The MPS2-AS test is ...
STAT

MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them

Pre-biopsy MRI is standard outside the U.S., but the latest data show such scans were done in only about a third of U.S.
ascopubs.org

Potential of urine liquid biopsy in detecting of clinically relevant genomic alterations in advanced genitourinary cancers.

Assessment of ctDNA detection in prostate cancer using a 6-base epigenomics and fragmentomics approach. GLP-1 receptor agonists vs 5-alpha reductase inhibitors for prostate cancer primary prevention ...
ascopubs.org

Predictive capability of combining ExoDx (EPI) and pre-biopsy prostate MRI in detecting clinically significant prostate cancer in African American men.

Inherited risk for prostate cancer (PCa): Following the natural history of men with increased genetic risk using multiparametric MRI (mpMRI).
Medical Xpress

AI tool can read prostate MRIs to help decide who needs a biopsy

Diagnostic tools based on artificial intelligence are now making their way into Norwegian hospitals. AI can independently read X-ray images and detect bone fractures, or assess cancer tumors in both ...